Results 51 to 60 of about 1,148,813 (206)

Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)

open access: yesGastroenterologìa
Hepatorenal syndrome is a critical and potentially life-threatening complication in patients with advanced liver cirrhosis, characterized by the development of renal dysfunction in the absence of underlying structural kidney disease.
M.I. Tutchenko   +4 more
doaj   +1 more source

Predictors of hepatorenal syndrome in alcoholic liver cirrhosis

open access: yesBiomedical Papers, 2015
Background: Alcoholic liver disease is a major cause of liver cirrhosis and the hepatorenal syndrome is a serious complication. Risk factors for hepatorenal syndrome (HRS) in alcoholic liver cirrhosis are not entirely explored.
Martin Janicko   +3 more
doaj   +1 more source

Do old urinary biomarkers have a place in the new definition of hepatorenal syndrome in the Egyptian cirrhotic patients? A single-center experience

open access: yesEgyptian Liver Journal, 2022
Background Hepatorenal syndrome is still a diagnosis of exclusion despite new classification. Aims To validate the accuracy of urinary neutrophil gelatinase-associated lipocalin, interleukin-18, and kidney injury molecule-1 in the new diagnostic criteria
Mona Abd El-Rahman Abu El-Makarem   +4 more
doaj   +1 more source

Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive Solutions

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
This review systematically summarizes a full spectrum of non‐invasive diagnostic approaches for portal hypertension (PH), including imaging modalities, elastography, serum biomarkers, composite scoring systems and endoscopic ultrasound‐guided portal pressure gradient (EUS‐PPG), and analyzes their performance across different liver disease etiologies ...
Lijia Yin, Huikuan Chu, Ling Yang
wiley   +1 more source

Longitudinal Assessment of Prognostic Factors for Patients with Hepatorenal Syndrome in a Tertiary Center

open access: yes, 2011
Hepatorenal syndrome (HRS) is one of the serious complications in patients with advanced cirrhosis and ascites. In tertiary centers, most patients were classified as having type 1 HRS for their rapid progressive diseases.
YANG, YA-WEN;WU, CHE-HSIUNG;HU, REY-HENG;TSAI, MENG-KUN;WU, YAO-MING;LEE, PO-HUANG   +1 more
core   +1 more source

Syndrome Hépatorénal : Aspects Epidémiologiques, Diagnostiques et Pronostiques

open access: yesHealth Research in Africa
RÉSUMÉ Introduction. Le syndrome Hépatorénal (SHR) est une forme particulière d’insuffisance rénale aigue fonctionnelle qui survient chez le patient atteint de cirrhose décompensée. Le traitement curatif reste la transplantation hépatique.
Ousseini F   +10 more
doaj   +1 more source

Therapeutic Properties and Underlying Mechanisms of Traditional Chinese Medicine in Managing Rheumatoid Arthritis: An Integrative Review of Clinical and Molecular Findings

open access: yesPhytotherapy Research, EarlyView.
The translational research framework integrating TCM for RA. The figure outlines a stepwise framework for the modernization and clinical translation of TCM in RA. Part 1 highlights the inheritance and development of TCM theory, including classical medical texts, traditional herbal knowledge, and syndrome differentiation–based treatment principles. Part
Jianting Wen   +4 more
wiley   +1 more source

Circulatory function and hepatorenal syndrome in cirrhosis

open access: yes, 2005
The pathogenic mechanism of hepatorenal syndrome is not well established. We investigated the circulatory function in cirrhosis before and after the development of hepatorenal syndrome.
Monescillo Francia, Alberto Fernando   +8 more
core   +1 more source

Combined Liver-Kidney Transplantation for Hepatorenal Syndrome

open access: yesInternational Journal of Organ Transplantation Medicine, 2015
Among various complications of end-stage liver disease, hepatorenal syndrome has the highest mortality. Patients with both end-stage liver disease and end-stage renal disease are candidates for combined liver-kidney transplantation.
V Kanubhai Sutariya   +2 more
doaj  

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy